Table 3.
Logistic regression analysis for the presence of heart failure with reduced ejection fraction
| Variable | OR (95% CI) | P value |
|---|---|---|
| UCP1 mRNA | 0.617 (0.103-0.989) | 0.042 |
| PGC1α mRNA | 0.416 (0.171-0.912) | 0.031 |
| PRMD16 mRNA | 0.643 (0.116-0.997) | 0.044 |
| Age | 1.643 (1.001-3.143) | 0.026 |
| Gender (man) | 7.867 (0.717-26.101) | 0.223 |
| Body mass index | 2.341 (0.683-8.033) | 0.312 |
| Obesity | 3.001 (0.843-12.301) | 0.323 |
| Diabetes mellitus | 4.031 (1.099-7.231) | <0.001 |
| Hypertension | 2.499 (0.798-14.133) | 0.492 |
| Dyslipidemia | 3.301 (0.639-9.103) | 0.329 |
| Coronary artery disease | 6.743 (1.932-15.301) | <0.001 |
Values were considered to be statistically significant when P<0.05.
CI: confidence Interval; OR: odds ratio; PGC1α: peroxisome proliferator-activated receptor gamma coactivator 1-alpha; PRDM16: PR-domain-missing 16; UCP1: uncoupling protein 1.